Nurse Practitioner · Denison, TX
NPI
1083355911
Since 2022
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5012 S US Highway 75 Ste 200
Denison, TX, 75020
Phone (903) 465-5012
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
3,164 services
Medicare patients, 2024
599
Average age 74
Drug cost, 2024
$3.0M
5,297 prescriptions
Company payments, 2025
$6,206
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Theresa D Englutt was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,875 times for 15 patients. In total Theresa D Englutt billed 3,164 services in 15 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,875 | 15 | $0.11 | $199 |
| 99214 Office E&M - Established | Office | 638 | 467 | $78.73 | $50K |
| 99213 Office E&M - Established | Office | 162 | 153 | $49.12 | $7,958 |
| 96372 Injection Administration | Office | 60 | 30 | $8.63 | $518 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 52 | 24 | $0.34 | $17.53 |
| 96401 Chemotherapy Administration | Office | 22 | 15 | $45.32 | $997 |
By year: 2023 $47K for 914 services; 2024 $68K for 3,164 services.
Medicare prescription drug claims, 2024
In 2024, the drug Theresa D Englutt prescribed most often to Medicare patients was Montelukast Sodium, with 798 prescriptions and refills. In total Theresa D Englutt wrote 5,297 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 798 | 1,780 | 300 | $8,028 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 640 | 827 | 253 | $18K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 633 | 940 | 203 | $597K |
| Azithromycin Generic | 249 | 572 | 147 | $4,344 |
| Zafirlukast Generic | 222 | 464 | 88 | $25K |
| Prednisone Generic | 213 | 347 | 130 | $935 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 189 | 265 | 69 | $166K |
| Omeprazole Generic | 145 | 291 | 45 | $1,692 |
| Roflumilast Generic | 113 | 179 | 32 | $7,764 |
| Mirtazapine Generic | 103 | 151 | 38 | $2,488 |
| Breo Ellipta Fluticasone/Vilanterol | 92 | 133 | 28 | $53K |
| Azelastine Hcl Generic | 89 | 165 | 42 | $2,666 |
| Spiriva Respimat Tiotropium Bromide | 85 | 115 | 27 | $58K |
| Ventolin Hfa Albuterol Sulfate | 80 | 90 | 39 | $5,473 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 77 | 91 | 26 | $6,591 |
Brand drugs: - claims; generic drugs: 3,263 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Theresa D Englutt $6,206 ($6,206 in general payments such as food, travel and fees) from 28 companies. The largest payer was Genzyme Corporation with $2,569.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 23 | $2,569 |
| GlaxoSmithKline, LLC. GSK | 42 | $475 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $422 |
| AOP Health US, LLC | 1 | $342 |
| Avadel CNS Pharmaceuticals, LLC | 5 | $281 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $247 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 19 | $231 |
| Viatris Specialty LLC | 11 | $189 |
| Actelion Pharmaceuticals US, Inc. JNJ | 4 | $178 |
| Axsome Therapeutics, Inc. AXSM | 11 | $170 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.